Byline: Will Doss
-
Chemotherapy Drug Mitigates Allergic Response
A drug originally designed as cancer therapy virtually eliminated allergic reactions in moderate cases and significantly lessened the risk of death in severe cases, according to a new study in animal models.
-
Chimeric Toxin Slows Cancer Growth
A novel compound using diphtheria toxin to attack a signaling pathway implicated in as many as 50 percent of cancers slowed tumor growth, according to a recent study.
-
New Role for RNA Splicing in Insulin Regulation
The gene transcription machinery that controls circadian rhythms also regulates insulin release in the pancreas, according to a Northwestern Medicine study.
-
Exploring Protein Vital for Bone Marrow Transplants
A protein called mDia2 is vital for proper bone marrow transplantation, according to a new study.
-
Strategies for Evaluating Breast Cancer with Machine Learning
Machine-learning technology could help pathologists more accurately assess how a patient’s immune system is responding to breast cancer, according to a recent series of reports authored in part by Feinberg faculty.
-
Remembering James Houk, PhD
James Houk, PhD, former chair and professor of Physiology whose Feinberg career spanned more than 40 years, passed away on June 11.
-
New Genetic Regulators Could Improve Cancer Immunotherapy
A genetic screen has revealed previously unknown regulators of Foxp3, a transcription factor that, when deactivated, may improve patient response to aggressive cancers.
-
Brain Synchronization Improves Odor Perception
Neurons in the olfactory cortex coordinate to boost the sense of smell when anticipating an odor, according to a Northwestern Medicine study.
-
Feet on the Ground
Building equitable relationships with community leaders and framing research questions around residents’ priorities is the core principle of community-engaged research, and IPHAM, along with ARCC, have been leaders in the field.
-
New Insights into Left Ventricular Cardiomyopathy
Genetic mutations in desmoplakin cause left ventricular cardiomyopathy, rather than right ventricular cardiomyopathy as previously believed, according to a recent study.
